Comparative Cycle Control Europe

NCT00185367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

798

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: EV/DNG (Qlaira, BAY86-5027, SH T00658K)
DRUG: SH D 593 B (Miranova)

Sponsor

Bayer